AKT1 and prostate carcinoma: Using GO6976 that specifically inhibits PKC α and β isoforms or shRNAs-PKC α/β, we showed that the pancreatic cancer cells harboring mutant K-ras or prostate cancer cells expressing active Akt are being efficiently sensitized to apoptosis, which again suggested the cooperation of these pathways.